1. Home
  2. CVKD vs VRAR Comparison

CVKD vs VRAR Comparison

Compare CVKD & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • VRAR
  • Stock Information
  • Founded
  • CVKD 2022
  • VRAR 2016
  • Country
  • CVKD United States
  • VRAR United States
  • Employees
  • CVKD N/A
  • VRAR N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • VRAR Retail: Computer Software & Peripheral Equipment
  • Sector
  • CVKD Health Care
  • VRAR Technology
  • Exchange
  • CVKD Nasdaq
  • VRAR Nasdaq
  • Market Cap
  • CVKD 29.5M
  • VRAR 31.5M
  • IPO Year
  • CVKD 2023
  • VRAR 2021
  • Fundamental
  • Price
  • CVKD $10.54
  • VRAR $1.44
  • Analyst Decision
  • CVKD Strong Buy
  • VRAR Strong Buy
  • Analyst Count
  • CVKD 1
  • VRAR 1
  • Target Price
  • CVKD $32.00
  • VRAR $2.62
  • AVG Volume (30 Days)
  • CVKD 27.7K
  • VRAR 975.0K
  • Earning Date
  • CVKD 08-11-2025
  • VRAR 09-29-2025
  • Dividend Yield
  • CVKD N/A
  • VRAR N/A
  • EPS Growth
  • CVKD N/A
  • VRAR N/A
  • EPS
  • CVKD N/A
  • VRAR N/A
  • Revenue
  • CVKD N/A
  • VRAR $8,756,789.00
  • Revenue This Year
  • CVKD N/A
  • VRAR $23.96
  • Revenue Next Year
  • CVKD N/A
  • VRAR $12.15
  • P/E Ratio
  • CVKD N/A
  • VRAR N/A
  • Revenue Growth
  • CVKD N/A
  • VRAR N/A
  • 52 Week Low
  • CVKD $5.70
  • VRAR $0.50
  • 52 Week High
  • CVKD $22.90
  • VRAR $7.00
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 37.37
  • VRAR 46.20
  • Support Level
  • CVKD $11.25
  • VRAR $1.52
  • Resistance Level
  • CVKD $11.88
  • VRAR $1.77
  • Average True Range (ATR)
  • CVKD 0.77
  • VRAR 0.17
  • MACD
  • CVKD -0.03
  • VRAR -0.00
  • Stochastic Oscillator
  • CVKD 2.95
  • VRAR 22.73

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.

Share on Social Networks: